Chardan Capital Initiates MannKind Coverage With Buy Rating, $10 Target
Chardan Capital initiated coverage of MannKind with a Buy rating and a $10.00 price target. The target implies 228.9% upside from the Oct. 16 close of $3.04.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.